COVID-19: Vaccines and Therapeutics

Mar 11, 2022
As the COVID-19 vaccine continues rolling out to pediatric populations, historically marginalized communities may have questions about the safety of the vaccine.
Mar 11, 2022
In a study of 1,364 children aged 5-15, two doses of the Pfizer COVID-19 vaccine reduced the risk of omicron infection by 31% in those under 12 and 59% in older children, the Centers for Disease Control and Prevention reported.
Mar 11, 2022
Puerto Rico governor applauds health care workers as the U.S. territory reaches a COVID-19 vaccine milestone.
Mar 10, 2022
An estimated 28% of children aged 5-11 received a first dose of the Pfizer COVID-19 vaccine between Nov. 1 and Jan. 18, while 19% received a second dose, according to a report released by the Centers for Disease Control and Prevention
Mar 10, 2022
The Centers for Medicare & Medicaid Services has released a Medicare payment code effective Feb. 24 for administering the combination monoclonal antibody therapy Evusheld to prevent COVID-19 in certain patients.
Mar 8, 2022
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response began distributing two COVID-19 antiviral pills directly to certain pharmacy-based clinics, federal health centers and long-term care facilities so their clinicians can prescribe them to…
Mar 3, 2022
The Senate last night voted 49-44 to approve a resolution calling for congressional disapproval of a Centers for Medicare…
Mar 1, 2022
The Centers for Disease Control and Prevention today released studies examining the effectiveness of the Pfizer COVID-19 vaccine at preventing emergency department and urgent care visits by children aged 5-17, and reactions to the Pfizer booster in adolescents aged 12-17.
Mar 1, 2022
Here are the top medical innovations the Cleveland Clinic sees for 2022, including next-gen of mRNA vaccinology, PSMA-targeted therapy for prostate cancer, novel drug treatment for type 2 diabetes, and artificial intelligence (AI) for early sepsis detection.
Feb 28, 2022
On this episode, I talk with Marcus Whitney, co-founder and partner of Jumpstart Health Investors, focused on innovation and investment in health care. Whitney also is founder and general partner of Jumpstart Nova, a venture fund investing in Black-led health care companies.